GENEVA, Aug. 31 -- BEIJING CHENGZHI LIFE SCIENCE CO., LTD. filed a patent application (CN2026/079825) for “USE OF D-RIBOSE IN IMPROVEMENT AND/OR PROTECTION OF MYOCARDIUM AND SKELETAL MUSCLE OF SUBJECT WITH ACCUMULATED EXERCISE-INDUCED FATIGUE”. With publication no. WO/2026/175421, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/7004

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....